DJIA 17,798.49 -14.90 -0.08%
NASDAQ 5,127.53 11.38 0.22%
S&P 500 2,090.11 1.24 0.06%
market minute promo

6.47 -0.05 (-0.77%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ARIA $6.47 -0.77%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $6.52
Previous Close $6.52
Daily Range $6.42 - $6.61
52-Week Range $5.55 - $10.07
Market Cap $1.2B
P/E Ratio -6.94
Dividend (Yield) $0.00 (0.0%)
Volume 986,535
Average Daily Volume 2,842,890
Current FY EPS -$1.16




Drug Makers

Ariad Pharmaceuticals, Inc. (ARIA) Description

The Company is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules. Website:

News & Commentary Rss Feed

Here's Why Ariad Pharmaceuticals Galloped Higher by 17% in October

A lack of broader Congressional follow-through on prescription drug reform lights a fire under Ariad shares in October.

Noteworthy Tuesday Option Activity: CLVS, ARIA, AJRD

ARIAD's Q3 Loss Wider than Expected; Iclusig Sales Fall

ARIAD Pharmaceuticals' (ARIA) CEO Harvey Berger on Q3 2015 Results - Earnings Call Transcript

ARIAD (ARIA) Posts Wider-than-Expected Loss in Q3

ARIAD Pharmaceuticals (ARIA) Q3 2015 Results - Earnings Call Webcast

Will ARIAD (ARIA) Disappoint Estimates in Q3 Earnings?

Cowen: In Biotech Earnings We Trust

Beware Of 'Glamour' Stocks - Part 2

Here's Why Ariad Pharmaceuticals Was Absolutely Pummeled in September

Ariad shareholders learned the hard way in September that betting on a buyout is not a smart investing strategy.

See More ARIA News...

ARIA's Top Competitors

ARIA $6.47 (-0.77%)
Current stock: ARIA
CELG $112.75 (0.36%)
Current stock: CELG
AMGN $163.52 (-0.26%)
Current stock: AMGN
BIIB $293.21 (0.31%)
Current stock: BIIB